Metformin in the Diastolic Dysfunction of Metabolic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Metabolic Syndrome XDiastolic DysfunctionInsulin Resistance
Interventions
BEHAVIORAL

Lifestyle Counseling

Written and individualized information during the interview in all clinic visits, emphasizing the importance of a healthy lifestyle, engaging on regular moderate-intensity physical activity and eating an healthy diet.

DRUG

Metformin

Metformin treatment titrated to a maximum dose of 1000mg twice a day. Metformin treatment will start with 500mg at breakfast during the first week and, if well tolerated, increased to 500mg twice a day (breakfast and dinner) in the second week, 1000mg at breakfast and 500mg at dinner in the third week and finally for the target dose of 1000mg twice a day.

Trial Locations (1)

4434-502

Gaia/Espinho Hospital Centre, Vila Nova de Gaia

All Listed Sponsors
collaborator

Centro Hospitalar de Vila Nova de Gaia/Espinho

OTHER

collaborator

Merck Serono International SA

INDUSTRY

lead

Universidade do Porto

OTHER

NCT02017561 - Metformin in the Diastolic Dysfunction of Metabolic Syndrome | Biotech Hunter | Biotech Hunter